纠正:在患有多发性硬化症的患者中,常见的COVID-19疫苗的安全性概况
Yasser S Aladdin1,2,3, Danah A Alqarni2, Sheifa W Alamoudi2
1Department of Neurology, Ministry of the National Guard-Health Affairs, Jeddah, SAU.
Cureus
|January 12, 2026
概括
这项研究纠正了先前发表的一篇文章. 校正确保了科学记录的准确引用和引用.
科学领域:
- 科学出版业的科学出版.
- 学术传播学术交流
- 学术诚信 学术诚信
背景情况:
- 准确的引用对于科学完整性至关重要.
- 适当的引用确保了研究的可复制性和可追溯性.
- 校正是学术出版过程的标准部分.
研究的目的:
- 为了正式纠正已发表文章的数字物体标识符 (DOI).
- 确保科学记录是准确和最新的.
- 维护学术交流的完整性.
主要方法:
- 发出了一份正式的纠正通知.
- 数字物体标识符 (DOI) 已经更新.
- 这项纠正发表在期刊的错误部分.
主要成果:
- 这篇文章的DOI已被纠正为10.7759/cureus.54852.
- 科学文献现在反映了研究的准确标识符.
- 这确保了正确的归因和对研究的访问.
结论:
- 校正维护了学术出版的标准.
- 准确的DOI对于研究人员定位和引用科学工作至关重要.
- 这确保了科学记录的可靠性.
相关概念视频
Vaccinations
51.2K
Overview
51.2K
Cancer Vaccines
945
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
945
Bioavailability Study Design: Healthy Subjects Versus Patients
140
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
140
Bioequivalence studies: Biowaivers
214
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
214
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
190
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
190
Bioavailability Study Design: Single Versus Multiple Dose Studies
193
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
193


